Anavex Life Sciences Corp (AVXL)

[kevindenver]

Strong enrollment numbers for their Parkinson disease trial with the possibility of Q2 interim analysis is what's driving $ANVS combined with a tiny number of outstanding shares.

I own it, but don't have any understanding of its MOA.
Very unlike the study time I've put into sigmar1 and muscarinic modulation and $AVXL.